These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208 [TBL] [Abstract][Full Text] [Related]
4. Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Cornelius JR; Salloum IM; Haskett RF; Ehler JG; Jarrett PJ; Thase ME; Perel JM Addict Behav; 1999; 24(1):111-4. PubMed ID: 10189977 [TBL] [Abstract][Full Text] [Related]
5. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder. Amsterdam JD; Shults J; Rutherford N Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ; CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients. Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594 [TBL] [Abstract][Full Text] [Related]
8. Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression. Sepede G; Racciatti D; Gorgoretti V; Nacci M; Pizzigallo E; Onofrj M; Di Giannantonio M; Niolu C; Salerno RM; Gambi F Int J Immunopathol Pharmacol; 2011; 24(4):1017-25. PubMed ID: 22230407 [TBL] [Abstract][Full Text] [Related]
9. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up. Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027 [TBL] [Abstract][Full Text] [Related]
10. Commentary on: randomised, double-blind, placebo-controlled trial of fluoxetine and graded exercise for chronic fatigue syndrome. Deale A; Chalder T; Wessely S Br J Psychiatry; 1998 Jun; 172():491-2. PubMed ID: 9828988 [No Abstract] [Full Text] [Related]
11. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. Vercoulen JH; Bazelmans E; Swanink CM; Fennis JF; Galama JM; Jongen PJ; Hommes O; Van der Meer JW; Bleijenberg G J Psychiatr Res; 1997; 31(6):661-73. PubMed ID: 9447571 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. Nemeroff CB; Thase ME; J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158 [TBL] [Abstract][Full Text] [Related]
13. Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial. Roerink ME; Knoop H; Bredie SJ; Heijnen M; Joosten LA; Netea MG; Dinarello CA; van der Meer JW Trials; 2015 Oct; 16():439. PubMed ID: 26438161 [TBL] [Abstract][Full Text] [Related]
14. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036 [TBL] [Abstract][Full Text] [Related]
15. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188 [TBL] [Abstract][Full Text] [Related]
16. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study. Macías-Cortés ED; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J Homeopathy; 2017 Feb; 106(1):3-10. PubMed ID: 28325221 [TBL] [Abstract][Full Text] [Related]
17. Double-blind fluoxetine in depressed alcoholic smokers. Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Black A; Perel JM; Thase ME Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770 [TBL] [Abstract][Full Text] [Related]
18. Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group. Small GW; Birkett M; Meyers BS; Koran LM; Bystritsky A; Nemeroff CB J Am Geriatr Soc; 1996 Oct; 44(10):1220-5. PubMed ID: 8856002 [TBL] [Abstract][Full Text] [Related]